Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation

被引:235
作者
Crouch, Peter J. [1 ,2 ,3 ]
Hung, Lin Wai [1 ,3 ,4 ]
Adlard, Paul A. [3 ]
Cortes, Mikhalina [3 ]
Lal, Varsha [3 ]
Filiz, Gulay [1 ,2 ,3 ]
Perez, Keyla A. [1 ,3 ,4 ]
Nurjono, Milawaty [3 ]
Caragounis, Aphrodite [1 ,2 ,3 ]
Du, Tai [1 ,2 ,3 ]
Laughton, Katrina [1 ,3 ]
Volitakis, Irene [1 ,3 ]
Bush, Ashley I. [3 ]
Li, Qiao-Xin [1 ,2 ,3 ]
Masters, Colin L. [3 ]
Cappai, Roberto [1 ,3 ,4 ]
Cherny, Robert A. [3 ]
Donnelly, Paul S. [4 ,5 ]
White, Anthony R. [1 ,2 ,3 ]
Barnham, Kevin J. [1 ,3 ,4 ]
机构
[1] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia
[4] Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Melbourne, Vic 3010, Australia
[5] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia
基金
澳大利亚研究理事会; 澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Alzheimer's disease; bioinorganic chemistry; glycogen synthase kinase; therapeutic; animal model; GLYCOGEN-SYNTHASE KINASE-3; IMPAIR SYNAPTIC PLASTICITY; AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MEDIATED NEURODEGENERATION; SOLUBLE OLIGOMERS; UP-REGULATION; COPPER;
D O I
10.1073/pnas.0809057106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cognitive decline in Alzheimer's disease (AD) involves pathological accumulation of synaptotoxic amyloid-beta (A beta) oligomers and hyperphosphorylated tau. Because recent evidence indicates that glycogen synthase kinase 3 beta (GSK3 beta) activity regulates these neurotoxic pathways, we developed an AD therapeutic strategy to target GSK3 beta. The strategy involves the use of copper-bis(thiosemicarbazonoto) complexes to increase intracellular copper bioavailability and inhibit GSK3 beta through activation of an Akt signaling pathway. Our lead compound Cu-II(gtsm) significantly inhibited GSK3 beta in the brains of APP/PS1 transgenic AD model mice. Cu-II(gtsm) also decreased the abundance of A beta trimers and phosphorylated tau, and restored performance of AD mice in the Y-maze test to levels expected for cognitively normal animals. Improvement in the Y-maze correlated directly with decreased A beta trimer levels. This study demonstrates that increasing intracellular copper bioavailability can restore cognitive function by inhibiting the accumulation of neurotoxic A beta trimers and phosphorylated tau.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 45 条
[1]   Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ [J].
Adlard, Paul A. ;
Cherny, Robert A. ;
Finkelstein, David I. ;
Gautier, Elisabeth ;
Robb, Elysia ;
Cortes, Mikhalina ;
Volitakis, Irene ;
Liu, Xiang ;
Smith, Jeffrey P. ;
Perez, Keyla ;
Laughton, Katrina ;
Li, Qiao-Xin ;
Charman, Susan A. ;
Nicolazzo, Joseph A. ;
Wilkins, Simon ;
Deleva, Karolina ;
Lynch, Toni ;
Kok, Gaik ;
Ritchie, Craig W. ;
Tanzi, Rudolph E. ;
Cappai, Roberto ;
Masters, Colin L. ;
Barnham, Kevin J. ;
Bush, Ashley I. .
NEURON, 2008, 59 (01) :43-55
[2]   Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes [J].
Arendash, GW ;
King, DL ;
Gordon, MN ;
Morgan, D ;
Hatcher, JM ;
Hope, CE ;
Diamond, DM .
BRAIN RESEARCH, 2001, 891 (1-2) :42-53
[3]   Tau-mediated neurodegeneration in Alzheimer's disease and related disorders [J].
Ballatore, Carlo ;
Lee, Virginia M. -Y. ;
Trojanowski, John Q. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (09) :663-672
[4]   Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β-amyloid [J].
Barnham, KJ ;
Haeffner, F ;
Ciccotosto, GD ;
Curtain, CC ;
Tew, D ;
Mavros, C ;
Beyreuther, K ;
Carrington, D ;
Masters, CL ;
Cherny, RA ;
Cappai, R ;
Bush, AI .
FASEB JOURNAL, 2004, 18 (10) :1427-+
[5]   Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals [J].
Blower, PJ ;
Castle, TC ;
Cowley, AR ;
Dilworth, JR ;
Donnelly, PS ;
Labisbal, E ;
Sowrey, FE ;
Teat, SJ ;
Went, MJ .
DALTON TRANSACTIONS, 2003, (23) :4416-4425
[6]   Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo [J].
Borchelt, DR ;
Thinakaran, G ;
Eckman, CB ;
Lee, MK ;
Davenport, F ;
Ratovitsky, T ;
Prada, CM ;
Kim, G ;
Seekins, S ;
Yager, D ;
Slunt, HH ;
Wang, R ;
Seeger, M ;
Levey, AI ;
Gandy, SE ;
Copeland, NG ;
Jenkins, NA ;
Price, DL ;
Younkin, SG .
NEURON, 1996, 17 (05) :1005-1013
[7]   Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands [J].
Caragounis, Aphrodite ;
Du, Tai ;
Filiz, Gulay ;
Laughton, Katrina M. ;
Volitakis, Irene ;
Sharples, Robyn A. ;
Cherny, Robert A. ;
Masters, Colin L. ;
Drew, Simon C. ;
Hill, Andrew F. ;
Li, Qiao-Xin ;
Crouch, Peter J. ;
Barnham, Kevin J. ;
White, Anthony R. .
BIOCHEMICAL JOURNAL, 2007, 407 :435-450
[8]   Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice [J].
Cherny, RA ;
Atwood, CS ;
Xilinas, ME ;
Gray, DN ;
Jones, WD ;
McLean, CA ;
Barnham, KJ ;
Volitakis, I ;
Fraser, FW ;
Kim, YS ;
Huang, XD ;
Goldstein, LE ;
Moir, RD ;
Lim, JT ;
Beyreuther, K ;
Zheng, H ;
Tanzi, RE ;
Masters, CL ;
Bush, AI .
NEURON, 2001, 30 (03) :665-676
[9]   Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease [J].
Crouch, Peter J. ;
Harding, Susan-Marie E. ;
White, Anthony R. ;
Camakaris, James ;
Bush, Ashley I. ;
Masters, Colin L. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (02) :181-198
[10]   Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42 [J].
Crouch, PJ ;
Blake, R ;
Duce, JA ;
Ciccotosto, GD ;
Li, QX ;
Barnham, KJ ;
Curtain, CC ;
Cherny, RA ;
Cappai, R ;
Dyrks, T ;
Masters, CL ;
Trounce, IA .
JOURNAL OF NEUROSCIENCE, 2005, 25 (03) :672-679